As mentioned earlier, not only has the Federal Trade Commission has filed a complaint in federal district court challenging agreements by Solvay Pharmaceuticals, which paid generic drug makers to delay launching generic versions of Solvay’s brand name drug AndroGel (known as “reverse payments“), but Senate Judiciary Committee members Herb Kohl (D-WI) and Chuck Grassley (R-IA) […]

Conducting an IP audit is a way for a firm to assess the nature and value of its intellectual property assets. Such assessments may be critical and more commonplace in certain industries, such as IT and pharmaceuticals.  However, in the wake of legislative changes and the current economic downturn, the potential value in conducting an […]

Indiana University’s Kelley School of Business last year started an online graduate level program, the Executive Certificate in the Business of Life Sciences (ECBLS).  George Telthorst, who helps run the program and is the Director of Business Development at the School’s Center for the Business of Life Sciences, wants us to help “spread the word” […]

Lawline.com is celebrating their 10 year anniversary of offering online Continuing Legal Education programs by implementing a new “Go Green” approach to our business.  Their Clean Law Initiative is aimed at reducing overall waste and increasing energy efficiency and sustainability. According to Lawline, accessing CLE online is by nature environmentally friendly.  Attorneys save millions of […]

The Federal Trade Commission has filed a complaint in federal district court challenging agreements by Solvay Pharmaceuticals, which paid generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay launching generic versions of Solvay’s brand name testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. According to the Commission’s […]

An English version of the current Examination Guidelines for Patent and Utility Model is available on the website of the Japan Patent Office (JPO). The document specifies the requirements for patent applications, giving detailed examples on issues such as “clarity” or “unity of application” according to the Japanese law.  These guidelines carry a lot of […]

On December 27, 2008, the Standing Committee of People’s National Congress approved amendments of the Chinese Patent Law. This third amendment aims at enhancing the innovation ability and enforcing protection of patent rights. Here’s a summary of the amendments most relevant to foreign clients: Direct Foreign Filing Available (A20) Now inventions/creations completed in China can […]